Akzo Nobel To Pay $36M In Third Settlement Over Remeron Patent Evergreening

Law360, New York (October 21, 2004, 12:00 AM EDT) -- Dutch drug maker Akzo Nobel has agreed to pay $36 million to settle a class-action lawsuit brought by U.S. states and public sector health purchasers over an alleged attempt to evergreen patents on the former blockbuster antidepressant Remeron.

Organon also has agreed to strong injunctive relief that will require the company to make timely listing of patents and prohibits Organon from submitting false or misleading listing information to the FDA, state attorneys general said in a statement.

The agreement follows a deal struck earlier this month...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.